Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 3/2019

15.12.2018 | Rhinology

Efficacy of allergen-blocker mechanical barrier gel on symptoms and quality of life in patients with allergic rhinitis

verfasst von: Seda Sirin Kose, Gizem Atakul, Suna Asilsoy, Ozkan Karaman, Nevin Uzuner, Ozden Anal

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Propose

Allergic rhinitis (AR) is a very common, chronic and global health problem. In the last two decades, the efficiency of barrier-enforcing measures in AR has been investigated. In this study, we aimed to evaluate the effect of allergen-blocker mechanical barrier gel (MBG) (AlerjiSTOP®) treatment on symptoms and quality of life score (QoLS) in patients with seasonal and perennial allergic rhinitis.

Methods

A single-center, prospective study was conducted between January 2017 and May 2018. Patients diagnosed with allergic rhinitis with a visual analogue scale (VAS) of 5 or higher (moderate/severe) were enrolled in the study. Patients were evaluated in terms of VAS, nasal symptom score (NSS), ocular symptom score (OSS), total symptom score (TSS) and QoLS at baseline, 1 week and 1 month of MBG treatment.

Results

A total of 83 patients with AR were enrolled in the study. Clinical and laboratory examinations showed that 50 (60.2%) patients were mono-sensitized. Allergen-blocker mechanical barrier gel treatment was performed as monotherapy in 22 (26.5%) patients. Median VAS, NSS, OSS and TSS decreased from 7 to 4, 8 to 3, 4 to 0 and 12 to 4, respectively (p < 0.0001). Correlation analysis revealed positive correlations between lower pediatric rhinoconjunctivitis quality of life questionnaire scores for patients under 12 years of age and decrease in VAS, NSS and TSS (r = 0.380, p = 0.008; r = 0.544, p < 0.0001; r = 0.543, p < 0.0001). Positive correlations were detected between lower rhinoconjunctivitis quality of life questionnaire (self-administered) scores for patients ≥ 12 years of age and decrease in VAS, NSS, OSS and TSS (r = 0.703, p < 0.0001; r = 0.465, p = 0.005; r = 0.526, p = 0.001; r = 0.624, p < 0.0001).

Conclusion

In conclusion, we found significant decrease in all symptom scores and improvement in QoLS of patients treated with MBG as monotherapy and combination therapy.
Literatur
1.
Zurück zum Zitat Bellanti JA, Wallerstedt DB (2000) Allergic rhinitis update: epidemiology and natural history. Allergy Asthma Proc 21:367–370CrossRefPubMed Bellanti JA, Wallerstedt DB (2000) Allergic rhinitis update: epidemiology and natural history. Allergy Asthma Proc 21:367–370CrossRefPubMed
2.
Zurück zum Zitat Bellanti JA, Settipane RA (2012) The burden of allergic rhinitis on patients’ quality of life. Allergy Asthma Proc 33:112CrossRefPubMed Bellanti JA, Settipane RA (2012) The burden of allergic rhinitis on patients’ quality of life. Allergy Asthma Proc 33:112CrossRefPubMed
3.
Zurück zum Zitat Benninger MS, Benninger RM (2009) The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc 30:358–365CrossRefPubMed Benninger MS, Benninger RM (2009) The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc 30:358–365CrossRefPubMed
4.
Zurück zum Zitat Bousquet J, Neukirch F, Bousquet PJ et al (2006) Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 117:158–162CrossRefPubMed Bousquet J, Neukirch F, Bousquet PJ et al (2006) Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 117:158–162CrossRefPubMed
5.
Zurück zum Zitat Meltzer EO, Blaiss MS, Naclerio RM et al (2012) Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc 33:113–141CrossRef Meltzer EO, Blaiss MS, Naclerio RM et al (2012) Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc 33:113–141CrossRef
6.
Zurück zum Zitat Juniper EF (1997) Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 99:742–749CrossRef Juniper EF (1997) Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 99:742–749CrossRef
7.
Zurück zum Zitat Bousquet J, Khaltaev N et al (2008) World Health Organization; GA(2)LEN; AllerGen. allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 86:8–160CrossRef Bousquet J, Khaltaev N et al (2008) World Health Organization; GA(2)LEN; AllerGen. allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 86:8–160CrossRef
8.
Zurück zum Zitat Angier E, Willington J, Scadding G, S. et al (2010) Management of allergic and non-allergic rhinitis: a primary care summary of the BSACI guideline. Prim Care Respir J 19:217–222CrossRefPubMed Angier E, Willington J, Scadding G, S. et al (2010) Management of allergic and non-allergic rhinitis: a primary care summary of the BSACI guideline. Prim Care Respir J 19:217–222CrossRefPubMed
9.
Zurück zum Zitat Josling P, Steadman S (2003) Use of cellulose powder for the treatment of seasonal allergic rhinitis. Adv Ther 20:213–219CrossRefPubMed Josling P, Steadman S (2003) Use of cellulose powder for the treatment of seasonal allergic rhinitis. Adv Ther 20:213–219CrossRefPubMed
10.
Zurück zum Zitat Emberlin JC, Lewis RA (2006) A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults. Curr Med Res Opin 22:275–285CrossRefPubMed Emberlin JC, Lewis RA (2006) A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults. Curr Med Res Opin 22:275–285CrossRefPubMed
11.
Zurück zum Zitat Cingi C, Unlu HH, Songu M et al (2010) Seawater gel in allergic rhinitis: entrapment effect and mucociliary clearance compared with saline. Ther Adv Respir Dis 4:13–18CrossRefPubMed Cingi C, Unlu HH, Songu M et al (2010) Seawater gel in allergic rhinitis: entrapment effect and mucociliary clearance compared with saline. Ther Adv Respir Dis 4:13–18CrossRefPubMed
12.
Zurück zum Zitat Böhm M, Avgitidou G, El Hassan E et al (2012) Liposomes: a new non-pharmacological therapy concept for seasonal-allergic-rhinoconjunctivitis. Eur Arch Otorhinolaryngol 269:495–502CrossRefPubMed Böhm M, Avgitidou G, El Hassan E et al (2012) Liposomes: a new non-pharmacological therapy concept for seasonal-allergic-rhinoconjunctivitis. Eur Arch Otorhinolaryngol 269:495–502CrossRefPubMed
13.
Zurück zum Zitat Eichel A, Bilstein A, Werkhäuser N et al (2014) Meta-analysis of the efficacy of ectoine nasal spray in patients with allergic rhinoconjunctivitis. J Allergy (Cairo) 2014:292545 Eichel A, Bilstein A, Werkhäuser N et al (2014) Meta-analysis of the efficacy of ectoine nasal spray in patients with allergic rhinoconjunctivitis. J Allergy (Cairo) 2014:292545
14.
Zurück zum Zitat Schwetz S, Olze H, Melchisedech S et al (2004) Efficacy of pollen blocker cream in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg 130:979–984CrossRefPubMed Schwetz S, Olze H, Melchisedech S et al (2004) Efficacy of pollen blocker cream in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg 130:979–984CrossRefPubMed
15.
Zurück zum Zitat Li Y, Wang D, Liu Q et al (2013) Randomized double-blind placebo-controlled crossover study of efficacy of pollen blocker cream for perennial allergic rhinitis. Am J Rhinol Allergy 27:299–303CrossRefPubMed Li Y, Wang D, Liu Q et al (2013) Randomized double-blind placebo-controlled crossover study of efficacy of pollen blocker cream for perennial allergic rhinitis. Am J Rhinol Allergy 27:299–303CrossRefPubMed
16.
Zurück zum Zitat Åberg N, Ospanova ST, Nikitin NP et al (2014) A nasally applied cellulose powder in seasonal allergic rhinitis in adults with grass pollen allergy: a double-blind, randomized, placebo-controlled, parallel-group study. Int Arch Allergy Immunol 163:313–318CrossRefPubMed Åberg N, Ospanova ST, Nikitin NP et al (2014) A nasally applied cellulose powder in seasonal allergic rhinitis in adults with grass pollen allergy: a double-blind, randomized, placebo-controlled, parallel-group study. Int Arch Allergy Immunol 163:313–318CrossRefPubMed
17.
Zurück zum Zitat Bousquet PJ, Combescure C, Neukirch F et al (2007) Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 62:367–372CrossRefPubMed Bousquet PJ, Combescure C, Neukirch F et al (2007) Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 62:367–372CrossRefPubMed
18.
Zurück zum Zitat Yüksel H, Yilmaz O, Söğüt A et al (2009) Validation and reliability study of the Turkish version of the Pediatric Rhinitis Quality of Life Questionnaire. Turk J Pediatr 51:361–366PubMed Yüksel H, Yilmaz O, Söğüt A et al (2009) Validation and reliability study of the Turkish version of the Pediatric Rhinitis Quality of Life Questionnaire. Turk J Pediatr 51:361–366PubMed
19.
Zurück zum Zitat Yuksel H, Yilmaz O, Alkan S et al (2009) Validity and reliability of Turkish version of rhinitis and mini-rhinitis quality of life questionnaires. Allergol Immunopathol (Madr) 37:293–297CrossRef Yuksel H, Yilmaz O, Alkan S et al (2009) Validity and reliability of Turkish version of rhinitis and mini-rhinitis quality of life questionnaires. Allergol Immunopathol (Madr) 37:293–297CrossRef
20.
Zurück zum Zitat Valerieva A, Popov TA, Staevska M et al (2015) Effect of micronized cellulose powder on the efficacy of topical oxymetazoline in allergic rhinitis. Allergy Asthma Proc 36:134–139CrossRef Valerieva A, Popov TA, Staevska M et al (2015) Effect of micronized cellulose powder on the efficacy of topical oxymetazoline in allergic rhinitis. Allergy Asthma Proc 36:134–139CrossRef
21.
Zurück zum Zitat Åberg N, Dahl Å, Benson M (2011) A nasally applied cellulose powder in seasonal allergic rhinitis (SAR) in children and adolescents; reduction of symptoms and relation to pollen load. Pediatr Allergy Immunol 22:594–599CrossRefPubMed Åberg N, Dahl Å, Benson M (2011) A nasally applied cellulose powder in seasonal allergic rhinitis (SAR) in children and adolescents; reduction of symptoms and relation to pollen load. Pediatr Allergy Immunol 22:594–599CrossRefPubMed
22.
Zurück zum Zitat Hoffman LR, Yen EH, Kanne JP et al (2005) Lipoid pneumonia due to Mexican folk remedies: cultural barriers to diagnosis. Arch Pediatr Adolesc Med 159:1043–1048CrossRefPubMed Hoffman LR, Yen EH, Kanne JP et al (2005) Lipoid pneumonia due to Mexican folk remedies: cultural barriers to diagnosis. Arch Pediatr Adolesc Med 159:1043–1048CrossRefPubMed
23.
Zurück zum Zitat Paz Lansberg M, DeTineo M, Lane J et al (2016) A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge. Am J Rhinol Allergy 30:269–273CrossRefPubMed Paz Lansberg M, DeTineo M, Lane J et al (2016) A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge. Am J Rhinol Allergy 30:269–273CrossRefPubMed
24.
Zurück zum Zitat Braunstahl GJ (2009) United airways concept: what does it teach us about systemic inflammation in airways disease? Proc Am Thorac Soc 6:652–654CrossRefPubMed Braunstahl GJ (2009) United airways concept: what does it teach us about systemic inflammation in airways disease? Proc Am Thorac Soc 6:652–654CrossRefPubMed
25.
Zurück zum Zitat Lightman S, Scadding GK (2012) Should intranasal corticosteroids be used for the treatment of ocular symptoms of allergic rhinoconjunctivitis? A review of their efficacy and safety profile. Int Arch Allergy Immunol 158:317–325CrossRefPubMed Lightman S, Scadding GK (2012) Should intranasal corticosteroids be used for the treatment of ocular symptoms of allergic rhinoconjunctivitis? A review of their efficacy and safety profile. Int Arch Allergy Immunol 158:317–325CrossRefPubMed
26.
Zurück zum Zitat Thompson AK, Juniper E, Meltzer EO (2000) Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 85:338–348CrossRefPubMed Thompson AK, Juniper E, Meltzer EO (2000) Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 85:338–348CrossRefPubMed
Metadaten
Titel
Efficacy of allergen-blocker mechanical barrier gel on symptoms and quality of life in patients with allergic rhinitis
verfasst von
Seda Sirin Kose
Gizem Atakul
Suna Asilsoy
Ozkan Karaman
Nevin Uzuner
Ozden Anal
Publikationsdatum
15.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 3/2019
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-018-5251-6

Weitere Artikel der Ausgabe 3/2019

European Archives of Oto-Rhino-Laryngology 3/2019 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.